Bank Julius Baer & Co. A.G., Guernsey Branch Stock

Certificat

SAAVJB

CH1216420815

Market Closed - Bid/Ask 11:20:00 2024-06-26 am EDT After market 11:15:00 am
251 CHF -1.38% Intraday chart for Bank Julius Baer & Co. A.G., Guernsey Branch 250.9 -0.05%
Current month+8.52%
1 month+8.56%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-26 251 -1.38%
24-06-25 254.5 -0.10%
24-06-24 254.8 +0.69%
24-06-21 253 +1.32%
24-06-20 249.7 +0.16%

Delayed Quote Swiss Exchange

Last update June 26, 2024 at 11:20 am EDT

More quotes

Static data

Product typeCertificati Sprint e Outperformance
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Bank Julius Bär
SAAVJB
ISINCH1216420815
Date issued 2023-02-07
Strike 284.5 CHF
Maturity 2024-08-07 (41 Days)
Parity 1 : 1
Emission price 284.5 CHF
Emission volume N/A
Settlement entrambi
Currency CHF

Technical Indicators

Highest since issue 299.5 CHF
Lowest since issue 214.4 CHF
Spread 1.25 CHF
Spread %0.50%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
249.6 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.40%
Consensus
  1. Stock Market
  2. Certificates
  3. SAAVJB Certificat